~~<i id='96F9F0FFF3'><strike id='96F9F0FFF3'><tt id='96F9F0FFF3'><pre id='96F9F0FFF3'></pre></tt></strike></i>~~

Home» knowledge» Wikipedia

Wikipedia

author：explore 2025-10-01 04:34:44 Page View：7372

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BIO: Crackdown on China pharma industry would threaten U.S. drug supply
Next article： Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

leisure time

Medicare details structure of new drug price negotiation program

MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

Close Medicare's dangerous gaps in addiction treatment coverage

YUKIIWAMURA/AFPviaGettyImagesWhilemanypeopleimmediatelypictureyoungadultswhenthinkingaboutthecurrent

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Cheap, fast test for Zika and dengue could cost just $1

NikolasAlbarranandJoseGomez-MarquezAnewblood testcancheaplyandquicklydistinguishbetweenthemosquito-b